Fibrocell Science market cap is $29.3 m.

Fibrocell Science Gross profit (Q3, 2019)-667 K

Fibrocell Science Gross profit margin (Q3, 2019), %(65.5%)

Fibrocell Science Net income (Q3, 2019)-7.2 M

Fibrocell Science EBIT (Q3, 2019)-4.4 M

Fibrocell Science Cash, 30-Sept-20196.8 M

Fibrocell Science EV27.5 M

USD | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 |
---|---|---|---|---|---|---|---|

## Revenue | 153.0k | 200.0k | 180.0k | 492.0k | 355.0k | ||

| (10%) | 173% | (28%) | ||||

## Cost of goods sold | 8.4m | 8.1m | 2.3m | 722.0k | 697.0k | ||

## Gross profit | (8.2m) | (7.9m) | (2.1m) | (230.0k) | (342.0k) | ||

| (5361%) | (3926%) | (1184%) | (47%) | (96%) | ||

## Sales and marketing expense | 2.2m | ||||||

## R&D expense | 9.0m | 12.6m | 16.2m | 10.0m | 8.4m | 6.5m | 6.0m |

## General and administrative expense | 12.2m | 10.1m | 11.6m | 11.3m | 9.8m | 6.7m | 6.4m |

## Operating expense total | 21.2m | 22.7m | 27.8m | 37.2m | 26.1m | 19.0m | 12.4m |

## Depreciation and amortization | 200.0k | ||||||

## EBIT | (29.4m) | (30.5m) | (30.0m) | (37.4m) | (26.5m) | (19.0m) | (12.4m) |

| (19209%) | (15251%) | (16641%) | (7603%) | (7459%) | ||

## Interest expense | 1.0m | 6.0k | 8.0k | 56.0k | 300.0k | ||

## Interest income | 368.0k | 17.0k | |||||

## Pre tax profit | (26.1m) | (30.6m) | (25.6m) | (34.5m) | (15.3m) | (16.2m) | (10.3m) |

## Income tax expense | (2.5m) | ||||||

## Net Income | (23.2m) | (30.6m) | (25.6m) | (34.5m) | (15.3m) | (16.2m) | (10.3m) |

USD | FY, 2011 | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 |
---|---|---|---|---|---|---|---|---|

## Cash | 10.8m | 31.3m | 60.0m | 37.5m | 29.3m | 17.5m | 17.4m | 14.4m |

## Accounts Receivable | 215.7k | 62.0k | 28.0k | 4.0k | ||||

## Prepaid Expenses | 1.2m | 1.3m | 1.2m | 1.3m | 1.2m | 485.0k | 105.0k | |

## Inventories | 266.3k | 477.0k | 597.0k | 571.0k | 482.0k | |||

## Current Assets | 12.5m | 33.2m | 61.9m | 39.3m | 31.0m | 18.0m | 17.9m | 14.5m |

## PP&E | 1.4m | 1.7m | 1.7m | 1.6m | 1.6m | 1.5m | 1.5m | 1.2m |

## Total Assets | 20.3m | 40.6m | 69.0m | 45.6m | 36.7m | 19.6m | 19.4m | 15.8m |

## Accounts Payable | 1.9m | 921.0k | 3.0m | 1.1m | 499.0k | 440.0k | 862.0k | 452.0k |

## Short-term debt | 6.7m | 1.1m | 1.7m | 2.2m | ||||

## Current Liabilities | 9.6m | 1.6m | 3.6m | 3.5m | 15.4m | 3.0m | 4.4m | 2.2m |

## Long-term debt | ||||||||

## Total Debt | 6.7m | 1.7m | ||||||

## Total Liabilities | 25.9m | 2.3m | 4.3m | 15.2m | 22.5m | 11.7m | 10.4m | 6.2m |

## Common Stock | 95.7k | 656.0k | 40.0k | 41.0k | 44.0k | 26.0k | 10.0k | |

## Preferred Stock | ||||||||

## Additional Paid-in Capital | 43.7m | 111.8m | 167.3m | 143.1m | 161.3m | 170.4m | 187.8m | 198.6m |

## Retained Earnings | (102.7m) | (112.7m) | (147.2m) | (162.6m) | (178.8m) | (189.1m) | ||

## Total Equity | (5.6m) | 38.3m | 64.7m | 30.4m | 14.2m | 7.9m | 9.0m | 9.6m |

## Debt to Equity Ratio | -1.2 x | 0.1 x | ||||||

## Debt to Assets Ratio | 0.3 x | 0 x | ||||||

## Financial Leverage | -3.6 x | 1.1 x | 1.1 x | 1.5 x | 2.6 x | 2.5 x | 2.2 x | 1.6 x |

USD | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 |
---|---|---|---|---|---|---|---|

## Net Income | (23.2m) | (30.6m) | (25.6m) | (34.5m) | (15.3m) | (16.2m) | (10.3m) |

## Depreciation and Amortization | 821.0k | 863.0k | 883.0k | 767.0k | 564.0k | 384.0k | 392.0k |

## Accounts Receivable | (60.0k) | 54.0k | 12.0k | 9.0k | 12.0k | ||

## Inventories | (477.0k) | (120.0k) | 26.0k | 89.0k | 126.0k | ||

## Accounts Payable | (966.0k) | 2.0m | (1.8m) | (114.0k) | (139.0k) | 69.0k | (24.0k) |

## Cash From Operating Activities | (22.6m) | (20.1m) | (22.3m) | (24.1m) | (29.4m) | (17.0m) | (12.7m) |

## Purchases of PP&E | (493.0k) | (360.0k) | (242.0k) | (271.0k) | (253.0k) | (433.0k) | (164.0k) |

## Cash From Investing Activities | 509.0k | (360.0k) | (242.0k) | (245.0k) | (252.0k) | (433.0k) | (164.0k) |

## Long-term Borrowings | (3.0k) | (2.0k) | |||||

## Dividends Paid | (470.0k) | ||||||

## Cash From Financing Activities | 42.6m | 49.1m | 16.1m | 17.9m | 17.4m | 9.9m | |

## Net Change in Cash | 20.5m | 28.7m | (22.5m) | (8.2m) | (11.8m) | (98.0k) | (3.0m) |

## Interest Paid | 1.9m | ||||||

## Income Taxes Paid |

USD | Q2, 2011 |
---|---|

## Debt/Equity | -0.3 x |

## Debt/Assets | 0.7 x |

## Financial Leverage | -0.4 x |